Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept

Background: Few studies exist that evaluate the therapeutic response among switchers of tumor necrosis antagonists in patients with psoriasis, especially Asian patients. Objective: This study aimed to evaluate the safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis w...

Full description

Bibliographic Details

Published in:	Dermatologica Sinica
Main Authors:	Ting-Shun Wang, Tsen-Fang Tsai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2013-03-01
Subjects:	adalimumab biologics etanercept psoriasis psoriasis area and severity index switch
Online Access:	http://www.sciencedirect.com/science/article/pii/S1027811712000791